Latest rheumatism Stories
Data presented today at EULAR 2012, the Annual Congress of the European League Against Rheumatism, demonstrates that tocilizumab monotherapy is more effective than adalimumab monotherapy in the treatment of rheumatoid arthritis (RA) based on change from baseline in DAS28 (-3.3 vs. -1.8, p
Data from a study presented today at EULAR 2012, the Annual Congress of the European League Against Rheumatism, demonstrates the vast inequalities in access to biologics for the treatments of rheumatoid arthritis (RA) across 46 European countries, with 22% (n=10) of countries having no biologic reimbursed at all.
As children with juvenile idiopathic arthritis (JIA) grow into adulthood, disability due to disease may adversely affect their ability to achieve educational success.
The Rheumatology and Surgery Sciences are two new key health categories covered by the Sciences Social Network.
An advisory panel recommends that the FDA consider approving Pfizer’s pill to treat rheumatoid arthritis. The pill, tofacitinib, would be sold to patients who don’t respond to traditional rheumatoid arthritis treatments.
African Americans have more severe complications from systemic sclerosis, also known as scleroderma, than Caucasians.
Children with juvenile idiopathic arthritis (JIA) have higher rates of hospitalized bacterial infection than children without JIA according to an observational study appearing in Arthritis & Rheumatism, a journal published by Wiley-Blackwell on behalf of the American College of Rheumatology (ACR).
Anxiety more common than depression among people with arthritis